Research Article
Treatment of Liver Fibrosis after Hepatitis B with TCM Combined with NAs Evaluated by Noninvasive Diagnostic Methods: A Retrospective Study
Table 1
Baseline characteristics of two groups.
| Characteristics | TCM users (n = 64) | TCM nonusers (n = 66) | value |
| Age (years) | <40 | 11 (17.2%) | 7 (10.6%) | 0.277 | ≥40 | 53 (82.8%) | 59 (89.4) | |
| Gender | Male | 49 | 41 | 0.074 | Female | 15 | 25 | |
| Duration of illness | 5∼10 | 53 | 50 | 0.322 | 10∼ | 11 | 16 | |
| Smoking history (n, %) | Yes | 2 | 1 | 0.978 | No | 62 | 65 | |
| Drinking history (n, %) | Yes | 0 | 2 | 0.490 | No | 64 | 64 | |
| Family history of CHB-related diseases (n, %) | Yes | 3 | 9 | 0.078 | No | 61 | 57 | |
| HBsAg | <250 | 15 | 22 | 0.211 | ≥250 | 49 | 44 | |
| HBeAg | Positive | 23 | 16 | 0.146 | Negative | 41 | 50 | |
| HBV DNA level (copies/mL) | <102 | 50 | 54 | 0.871 | 102∼103 | 7 | 6 | | 103∼104 | 7 | 6 | |
| ALT (IU/ml ULN) | 1∼2 | 45 | 54 | 0.124 | 2∼3 | 19 | 12 | |
| LSM | 7∼9 | 12 | 21 | 0.087 | ≥9 | 52 | 45 | |
|
|